BFRI logo

Biofrontera (BFRI) Cash From Operations

Annual CFO

-$24.89 M
-$8.70 M-53.68%

December 1, 2023


Summary


Performance

BFRI Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBFRIcash flowmetrics:

Quarterly CFO

-$1.21 M
+$3.51 M+74.41%

September 1, 2024


Summary


Performance

BFRI Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBFRIcash flowmetrics:

TTM CFO

-$18.12 M
+$796.00 K+4.21%

September 1, 2024


Summary


Performance

BFRI TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBFRIcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BFRI Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-53.7%+86.4%+27.2%
3 y3 years-101.3%+86.4%+27.2%
5 y5 years+33.9%+86.4%+27.2%

BFRI Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-53.7%+6.8%-1066.4%+94.2%-11.8%+37.3%
5 y5-year-101.3%+33.9%-1066.4%+94.2%-426.3%+37.3%
alltimeall time-101.3%+33.9%-1066.4%+94.2%-426.3%+37.3%

Biofrontera Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.21 M(-74.4%)
-$18.12 M(-4.2%)
Jun 2024
-
-$4.72 M(+42.0%)
-$18.91 M(-22.9%)
Mar 2024
-
-$3.33 M(-62.5%)
-$24.53 M(-1.5%)
Dec 2023
-$24.89 M(+53.7%)
-$8.87 M(+342.4%)
-$24.89 M(+2.4%)
Sep 2023
-
-$2.00 M(-80.6%)
-$24.30 M(-13.9%)
Jun 2023
-
-$10.34 M(+180.2%)
-$28.24 M(+58.8%)
Mar 2023
-
-$3.69 M(-55.4%)
-$17.78 M(+9.7%)
Dec 2022
-$16.20 M
-$8.27 M(+39.2%)
-$16.20 M(-44.0%)
Sep 2022
-
-$5.94 M(-4852.8%)
-$28.92 M(+19.5%)
DateAnnualQuarterlyTTM
Jun 2022
-
$125.00 K(-105.9%)
-$24.19 M(-4.7%)
Mar 2022
-
-$2.11 M(-89.9%)
-$25.38 M(-5.0%)
Dec 2021
-$26.71 M(+116.0%)
-
-
Dec 2021
-
-$20.99 M(+1624.7%)
-$26.71 M(+366.6%)
Sep 2021
-
-$1.22 M(+14.3%)
-$5.72 M(+27.0%)
Jun 2021
-
-$1.06 M(-69.1%)
-$4.51 M(+30.9%)
Mar 2021
-
-$3.44 M
-$3.44 M
Dec 2020
-$12.37 M(-67.2%)
-
-
Dec 2019
-$37.68 M
-
-

FAQ

  • What is Biofrontera annual cash flow from operations?
  • What is the all time high annual CFO for Biofrontera?
  • What is Biofrontera annual CFO year-on-year change?
  • What is Biofrontera quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Biofrontera?
  • What is Biofrontera quarterly CFO year-on-year change?
  • What is Biofrontera TTM cash flow from operations?
  • What is the all time high TTM CFO for Biofrontera?
  • What is Biofrontera TTM CFO year-on-year change?

What is Biofrontera annual cash flow from operations?

The current annual CFO of BFRI is -$24.89 M

What is the all time high annual CFO for Biofrontera?

Biofrontera all-time high annual cash flow from operations is -$12.37 M

What is Biofrontera annual CFO year-on-year change?

Over the past year, BFRI annual cash flow from operations has changed by -$8.70 M (-53.68%)

What is Biofrontera quarterly cash flow from operations?

The current quarterly CFO of BFRI is -$1.21 M

What is the all time high quarterly CFO for Biofrontera?

Biofrontera all-time high quarterly cash flow from operations is $125.00 K

What is Biofrontera quarterly CFO year-on-year change?

Over the past year, BFRI quarterly cash flow from operations has changed by +$7.66 M (+86.37%)

What is Biofrontera TTM cash flow from operations?

The current TTM CFO of BFRI is -$18.12 M

What is the all time high TTM CFO for Biofrontera?

Biofrontera all-time high TTM cash flow from operations is -$3.44 M

What is Biofrontera TTM CFO year-on-year change?

Over the past year, BFRI TTM cash flow from operations has changed by +$6.78 M (+27.22%)